Evidence map›Paper›PMID 30102745›Full record

ArticlePLoS pathogens2018

Salmonella Typhimurium effector SseI inhibits chemotaxis and increases host cell survival by deamidation of heterotrimeric Gi proteins.

Thorsten Brink, Veronika Leiss, Peter Siegert, Doris Jehle, Julia K Ebner, Carsten Schwan, Aliaksei Shymanets, Sebastian Wiese, Bernd Nürnberg, Michael Hensel and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. The Manipulation of Host Cells byInternational journal of molecular sciences · 2026
    Review
  2. International journal of molecular sciences · 2025
    Review
  3. microLife · 2024
    Article
  4. Tropical medicine and infectious disease · 2023
    Review
  5. Article
  6. Article
  7. Speaking the host language: howMicrobiology (Reading, England) · 2023
    Review
  8. Review
  9. Antibiotic Resistance in Non-TyphoidalPathogens (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Pathogenic signature of invasive non-typhoidalHuman vaccines & immunotherapeutics · 2020
    Review
  13. Microorganisms · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Thorsten BrinkInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Veronika LeissAbteilung für Pharmakologie und Experimentelle Therapie, Medizinische Fakultät und ICePhA, Eberhard-Karls-Universität Tübingen, Germany.
Peter SiegertInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Doris JehleInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Julia K EbnerInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Carsten SchwanInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Aliaksei ShymanetsAbteilung für Pharmakologie und Experimentelle Therapie, Medizinische Fakultät und ICePhA, Eberhard-Karls-Universität Tübingen, Germany.
Sebastian WieseZentrum für Biosystemanalyse, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.ORCID 0000-0001-5697-2608
Bernd NürnbergAbteilung für Pharmakologie und Experimentelle Therapie, Medizinische Fakultät und ICePhA, Eberhard-Karls-Universität Tübingen, Germany.
Michael HenselAbteilung Mikrobiologie, Fachbereich Biologie/Chemie, Universität Osnabrück, Osnabrück, Germany.ORCID 0000-0001-6604-6253
Klaus AktoriesInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.ORCID 0000-0002-5397-0436
Joachim H C OrthInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
University of Freiburg · DEUniversity of Tübingen · DEOsnabrück University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salmonella enterica serotype Typhimurium (S. Typhimurium) is one of the most frequent causes of food-borne illness in humans and usually associated with acute self-limiting gastroenteritis. However, in immunocompromised patients, the pathogen can disseminate and lead to severe systemic diseases. S. Typhimurium are facultative intracellular bacteria. For uptake and intracellular life, Salmonella translocate numerous effector proteins into host cells using two type-III secretion systems (T3SS), which are encoded within Salmonella pathogenicity islands 1 (SPI-1) and 2 (SPI-2). While SPI-1 effectors mainly promote initial invasion, SPI-2 effectors control intracellular survival and proliferation. Here, we elucidate the mode of action of Salmonella SPI-2 effector SseI, which is involved in control of systemic dissemination of S. Typhimurium. SseI deamidates a specific glutamine residue of heterotrimeric G proteins of the Gαi family, resulting in persistent activation of the G protein. Gi activation inhibits cAMP production and stimulates PI3-kinase γ by Gαi-released Gβγ subunits, resulting in activation of survival pathways by phosphorylation of Akt and mTOR. Moreover, SseI-induced deamidation leads to non-polarized activation of Gαi and, thereby, to loss of directed migration of dendritic cells.

Indexed as

ChemotaxisSalmonella typhimuriumAnimalsBacterial ProteinsCell SurvivalDeaminationFemaleGTP-Binding Protein alpha Subunits, Gi-GoHEK293 CellsHeLa CellsHost-Pathogen InteractionsHumansMaleMiceMice, Inbred C57BLMice, KnockoutBacterial ProteinsGTP-Binding Protein alpha Subunits, Gi-GoType III Secretion Systems

Identifiers

PMID30102745
PMCPMC6107295
OpenAlexW2887596390

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.